ATYR PHARMA INC (ATYR) Stock Analyst Ratings
USA - NASDAQ:ATYR - US0021202025 - Common Stock
0.9859 USD
+0.02 (+1.64%)
ChartMill assigns a Buy % Consensus number of 74% to ATYR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.31. This target is 946.08% above the current price.
ATYR was analyzed by 17 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about ATYR.
In the last month the buy percentage fell by 10 points. So the trust of analysts is decreasing.
ATYR was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-16 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-09-16 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-09-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-08-22 | Jefferies | Maintains | Buy -> Buy |
| 2025-06-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-18 | Leerink Partners | Initiate | Outperform |
| 2025-01-06 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-04 | Wells Fargo | Initiate | Overweight |
| 2024-09-05 | Jefferies | Initiate | Buy |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
ATYR PHARMA INC / ATYR FAQ
What is the average price target for ATYR PHARMA INC (ATYR) stock?
17 analysts have analysed ATYR and the average price target is 10.31 USD. This implies a price increase of 946.08% is expected in the next year compared to the current price of 0.9859.
What is the consensus rating for ATYR PHARMA INC (ATYR) stock?
The consensus rating for ATYR PHARMA INC (ATYR) is 74.1176 / 100 . This indicates that analysts generally have a positive outlook on the stock.